MedTrace Logo

Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study

NCT03432429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2022-03-31

No results posted yet for this study

Summary

REI-EXCISE is a multicentre, prospective, non-randomised feasibility study, aimed to evaluate the diagnostic accuracy of rapid ionisation mass spectroscopy using an iKnife device. The iKnife will collect vapour, a by-product of surgery, which will pass through the mass spectrometer machine for analysis in order to evaluate what is "normal" and what is "cancerous" breast tissue.

Conditions

Interventions

OTHER

REIMS iKnife

Use of REIMS iKnife in breast conserving surgery

Sponsors & Collaborators

  • Cancer Research UK

    collaborator OTHER

  • Waters Corporation

    collaborator UNKNOWN

  • Imperial College London

    lead OTHER

Principal Investigators

  • Daniel Leff · Department of Surgery & Cancer, Imperial College London

  • Zoltan Takats · Department of Metabolism, Digestion and Reproduction, Imperial College London

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2021-12-08
Completion
2021-12-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03432429 on ClinicalTrials.gov